DULIGOTUZUMAB
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Receptor tyrosine-protein kinase erbB-3 inhibitor | no | 2 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Receptor tyrosine-protein kinase erbB-3 inhibitor | no | 2 | 0 |